Mostrar registro simples

dc.contributor.authorBorges, Flávia Kesslerpt_BR
dc.contributor.authorFurtado, Mariana Vargaspt_BR
dc.contributor.authorRossini, Ana Paula Webberpt_BR
dc.contributor.authorBertoluci, Carolinapt_BR
dc.contributor.authorGonzalez, Vinícius Leitept_BR
dc.contributor.authorBertoldi, Eduardo Gehlingpt_BR
dc.contributor.authorPezzali, Luíza Guazzellipt_BR
dc.contributor.authorMachado, Daniel Luftpt_BR
dc.contributor.authorGrutcki, Denis Maltzpt_BR
dc.contributor.authorRech, Leandro Gazzieropt_BR
dc.contributor.authorMagalhães, Marianapt_BR
dc.contributor.authorPolanczyk, Carisi Annept_BR
dc.date.accessioned2017-09-13T02:28:14Zpt_BR
dc.date.issued2013pt_BR
dc.identifier.issn0278-0240pt_BR
dc.identifier.urihttp://hdl.handle.net/10183/166261pt_BR
dc.description.abstractBackground. Cardiac troponin levels have been reported to add value in the detection of cardiovascular complications in noncardiac surgery. A sensitive cardiac troponin I (cTnI) assay could provide more accurate prognostic information. Methods. This study prospectively enrolled 142 patients with at least one Revised Cardiac Risk Index risk factor who underwent noncardiac surgery. cTnI levels were measured postoperatively. Short-term cardiac outcome predictors were evaluated. Results. cTnI elevation was observed in 47 patients, among whom 14 were diagnosed as having myocardial infarction (MI). After 30 days, 16 patients had major adverse cardiac events (MACE). Excluding patients with a final diagnosis of MI, predictors of cTnI elevation included dialysis, history of heart failure, transoperativemajor bleeding, and elevated levels of pre- and postoperativeN-terminal pro-B-type natriuretic peptide (NT-proBNP). Maximal cTnI values showed the highest sensitivity (94%), specificity (75%), and overall accuracy (AUC 0.89; 95% CI 0.80–0.98) for postoperative MACE. Postoperative cTnI peak level (OR 9.4; 95% CI 2.3–39.2) and a preoperative NT-proBNP level ≥917 pg/mL (OR 3.47; 95% CI 1.05–11.6) were independent risk factors for MACE. Conclusions. cTnI was shown to be an independent prognostic factor for cardiac outcomes and should be considered as a component of perioperative risk assessment.en
dc.format.mimetypeapplication/pdfpt_BR
dc.language.isoengpt_BR
dc.relation.ispartofDisease markers. Chichester. Vol. 35, no. 6 (2013), p. 945-953.pt_BR
dc.rightsOpen Accessen
dc.subjectInfarto do miocárdiopt_BR
dc.subjectEstimativa de Kaplan-Meierpt_BR
dc.subjectPeríodo pós-operatóriopt_BR
dc.subjectSeleção de pacientespt_BR
dc.subjectTroponina Ipt_BR
dc.subjectResultado do tratamentopt_BR
dc.subjectCurva ROCpt_BR
dc.titleClinical use of ultrasensitive cardiac troponin I assay in intermediate- and high-risk surgery patientspt_BR
dc.typeArtigo de periódicopt_BR
dc.identifier.nrb001046329pt_BR
dc.type.originEstrangeiropt_BR


Thumbnail
   

Este item está licenciado na Creative Commons License

Mostrar registro simples